Abstract 11P
Background
Breast cancer is the second leading cause of cancer deaths in women worldwide. Early detection of breast cancer has been demonstrated to improve patients' treatment outcomes and survival. Liquid biopsy based on detecting DNA shed by breast tumors into the circulation, known as circulating tumor DNA (ctDNA), has emerged as a promising non-invasive approach. However, differentiating benign breast lumps from malignant tumors remains a challenge in current clinical practice, and inaccurate detection may result in unnecessary invasive procedures.
Methods
To address this challenge, we employed a multimodal analysis approach, namely SPOT-MAS (Screen for the Presence of Tumor by DNA Methylation and Size) to profile alterations in methylation and fragment length patterns of cell free DNA (cfDNA) from 133 breast cancer patients and 59 patients with benign breast lumps comprising cysts and fibroadenomas.
Results
We identified multiple distinct end motifs, differential methylation and fragment length patterns across 22 chromosomes, which were further exploited as input features to build machine learning models to discriminate early-stage breast cancer patients from patients with benign lesions. The models achieved an area under the curve of 0.87 (95% CI: 0.79 – 0.94) and a sensitivity of 64.1% at 90% specificity in detecting patients with malignant tumors.
Conclusions
Therefore, our findings demonstrated that cancer-specific methylation and fragmentomic patterns in plasma cfDNA could serve as novel biomarkers for accurately differentiating malignant breast cancer patients from those with benign lesions.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Medical Genetics Institute and Gene Solutions Joint Stock Company, Vietnam.
Funding
Gene Solutions Joint Stock Company.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
281P - 10-year treatment outcome of prostate cancer patients with 3D conformal radiation: Experience of a single cancer institution in Iran
Presenter: Reyhane Bayani
Session: Poster Display
Resources:
Abstract
282P - Predictors of outcomes in patients with clinically lymph node-positive prostate cancer after definitive radiotherapy
Presenter: Jae-Sung Kim
Session: Poster Display
Resources:
Abstract
283P - Radiotherapy utilization rate and treatment patern of protate cancer at Cipto Mangunkusumo Central General Hospital (RSCM): What we learn from pre-pandemic era
Presenter: Riyan Apriantoni
Session: Poster Display
Resources:
Abstract
284TiP - CYCLONE 3: A phase III, randomized, double-blind, placebo-controlled study of abemaciclib in combination with abiraterone plus prednisone in men with high-risk metastatic hormone-sensitive prostate cancer
Presenter: Nobuaki Matsubara
Session: Poster Display
Resources:
Abstract
292P - Comparative characteristics of early cervical cancer diagnosis methods for Tashkent women
Presenter: Gulnoza Goyibova
Session: Poster Display
Resources:
Abstract
293P - Carboplatin in locally advanced cervical cancer treated with chemoradiation: An alternative to cisplatin
Presenter: Natalia Isabel Valdiviezo Lama
Session: Poster Display
Resources:
Abstract
294P - Concurrent chemoradiation with cisplatin every 3 weeks in locally advanced cervical cancer: A single arm phase II clinical trial
Presenter: Long Nguyen
Session: Poster Display
Resources:
Abstract
295P - A prospective study of dose escalated simultaneous integrated boost in node-positive cervical cancer
Presenter: Ritusha Mishra
Session: Poster Display
Resources:
Abstract
296P - Safety, efficacy, and immunogenicity of therapeutic vaccines for patients with high-grade cervical intraepithelial neoplasia (CIN 2/3) associated with human papillomavirus: A systematic review
Presenter: Caroline Amélia Gonçalves
Session: Poster Display
Resources:
Abstract
297P - The utilization rate of radiotherapy and chemotherapy for cervical cancer in Indonesia: Optimal versus actual, how far the gap?
Presenter: Charity Kotambunan
Session: Poster Display
Resources:
Abstract